![Norman Ruchholtz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Norman Ruchholtz
Algemeen Directeur bij Cantourage GmbH
Profiel
Norman Ruchholtz is associated with two companies, Cantourage Group SE and Cantourage GmbH, both of which he founded in 2019.
At Cantourage GmbH, he holds the title of Managing Director.
Actieve functies van Norman Ruchholtz
Bedrijven | Functie | Begin |
---|---|---|
Cantourage GmbH
![]() Cantourage GmbH Pharmaceuticals: MajorHealth Technology Part of Cantourage Group SE, Cantourage GmbH is a leading European medical cannabis company based in Kleinmachnow, Germany. The German company focuses on long-term collaborations and strategic partnerships to provide patients with an unprecedented selection of the highest quality cannabis medicines at affordable prices. Cantourage offers products in all relevant market segments, including dried flowers, extracts, dronabinol, and pharma-grade cannabidiol. Cantourage's unique fast track access platform enables producers from across the world to become part of the rapidly growing European medical cannabis market, providing medical cannabis-related products to millions of people in Europe. The company was founded in 2019 by Florian Holzapfel, Patrick Hoffmann, and Norman Ruchholtz, who has been the CEO since 2019. | Algemeen Directeur | 01-01-2019 |
Eerdere bekende functies van Norman Ruchholtz
Bedrijven | Functie | Einde |
---|---|---|
CANTOURAGE GROUP SE | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CANTOURAGE GROUP SE | Process Industries |
Bedrijven in privébezit | 1 |
---|---|
Cantourage GmbH
![]() Cantourage GmbH Pharmaceuticals: MajorHealth Technology Part of Cantourage Group SE, Cantourage GmbH is a leading European medical cannabis company based in Kleinmachnow, Germany. The German company focuses on long-term collaborations and strategic partnerships to provide patients with an unprecedented selection of the highest quality cannabis medicines at affordable prices. Cantourage offers products in all relevant market segments, including dried flowers, extracts, dronabinol, and pharma-grade cannabidiol. Cantourage's unique fast track access platform enables producers from across the world to become part of the rapidly growing European medical cannabis market, providing medical cannabis-related products to millions of people in Europe. The company was founded in 2019 by Florian Holzapfel, Patrick Hoffmann, and Norman Ruchholtz, who has been the CEO since 2019. | Health Technology |